Clinical Trial Update: Effect of Short-term Synbiotic Treatment on Plasma P-cresol Levels in Hemodialysis Patients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluating whether short-term synbiotic therapy reduces plasma p-cresol levels in patients undergoing hemodialysis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• Synbiotic treatment

Snippet

Sponsor: Federico II University | Conditions: Hemodialysis | Phase 4 | Status: UNKNOWN